Medstar Washington Hospital Center, Washington, DC
Vishal Navnitray Ranpura, Lynne Wood, Stephanie Heller, Linda Self, Sekwon Jang
Background: Medstar Washington Cancer Institute (MWCI) has participated in Quality Oncology Practice Initiative (QOPI) since 2008. Adherence to pain assessment and intensity documentation was high, but lower in plan of care for moderate/severe pain documentation (69%, compared to QOPI aggregate of 79%) during the fall 2011 round. One potential explanation for the discrepancy was lack of communication between the nursing staff assessing the pain and the physician treating pain. We hypothesized that the use of pain card can improve the communication between nurses and doctors, as well as prompt physicians to document the plan of care for moderate/severe pain. Methods: MWCI created a team of physicians, nurses, quality resources, and administrative staff in December 2011. We abstracted up to 10 patients charts per oncologist for those patientswho reported moderate to severe pain (pain score of more than 3 of 10 on numeric rating scale) each quarter during 2012.We used data for quarter 1 and 2 as a baseline. We implemented the use of pain card by nurses to report pain for these patients to the physician in quarter 3 and 4. Chi square test was used to compare documentation rate in the first two quarters and last two quarters. Results: The total number of charts evaluated, pain documentation as well as confidence intervals for each quarter are shown in the table. Our results show significant improvement in pain documentation by physician in last two quarters compared to first two quarters ( p = 0.0007). Conclusions: Our study demonstrates pain card improved communication between nurse and physician resulting improved documentation of pain by physician.
Year 2012 | Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 |
---|---|---|---|---|
Total charts reviewed | 80 | 76 | 80 | 85 |
Number of charts with pain documentation | 46 | 36 | 53 | 64 |
Percentage of charts with pain documentation (95% confidence interval, percentage) |
58% (47.18-68.82%) |
47% (35.78-58.22%) |
66% (55.62-76.38%) |
75% (65.79-84.21%) |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2022 ASCO Quality Care Symposium
First Author: Aditya V. Shreenivas
2013 ASCO Annual Meeting
First Author: Sekwon Jang
2023 ASCO Annual Meeting
First Author: Winette T.A. Van Der Graaf
2021 ASCO Annual Meeting
First Author: Harold Nathan C. Tan